VC-Backed Chlorogen Shuts Down

Chlorogen Inc., a St. Louis-based developer of a protein-based therapy for gynecological cancer, has ceased operations, and is in the process of selling its technology assets. The company had raised over $15 million in VC funding from firms like Finistere Partners, Burrill & Co., Harris & Harris Group, Prolog Ventures and Redmont Venture Partners.